Abstract: A method of citing a parking violation includes locating a removable locking device around a wheel of the vehicle. The locking device is located to permit the mobility of the vehicle but act as a nuisance when in motion. A driver is permitted to settle the infraction through multiple ways wherein the driver pays a fee for the infraction and a core fee for the locking device. The core fee may be refunded upon successful return of the locking device to a collection unit. The act of ticketing and securing the vehicle are done in a concurrent set of steps.

Abstract: Systems and methods to automatically generate signatures used to detect malware are provided. The systems and methods use machine learning techniques, to build an over-trained heuristic model to analyze software, cluster identified patterns, validate the clusters against known reputational metrics, automatically create signatures and, in some examples, deploy such signatures to remote computing devices.

Abstract: A computer-implemented method for scanning a file is described. A Golomb-Compressed Sequence (GCS) index may be queried to determine whether GCS data is associated with the scanned data. The GCS index may be stored in a first storage medium and the GCS data may be stored in a second storage medium. The second storage medium may be different from the first storage medium. Upon determining the GCS data is associated with the scanned data, the location of the GCS data associated with the scanned data may be identified. The GCS data may be retrieved from the identified location. At least a portion of the retrieved GCS data may be analyzed. Based on the analysis of the retrieved GCS data, it may be determined whether to perform additional data querying.

Abstract: A composition for removing urethane products from a wide variety of substrates without the need for scraping, scrubbing, sanding, sandblasting and the like is provided. The composition is formed by combining water, a polar organic solvent, a mixture of organic esters, a hydrocarbon, and a polyether. The composition may optionally be formed by combining the components recited above along with an anionic surfactant. The composition may optionally be formed by combining the components recited above along with a thickener.

Abstract: A computing system for providing a user interface control to modify properties of items within a main application window. The computing system has a main application window, a gallery control window, a control object selection processing module, and a control object focus processing module. The main application window contains one or more application items, each application item having one or more control properties affecting a behavior of the application item. The gallery control window contains a list of one or more control objects for modifying control properties of the application items located within the main application window. Each of the control objects in the list of control objects includes a graphical icon having a selection portion and a properties portion and one or more control properties that affect one or more items within the main application window.

Abstract: A computing system for providing a user interface control to modify properties of items within a main application window. The computing system has a main application window, a gallery control window, a control object selection processing module, and a control object focus processing module. The main application window contains one or more application items, each application item having one or more control properties affecting a behavior of the application item. The gallery control window contains a list of one or more control objects for modifying control properties of the application items located within the main application window. Each of the control objects in the list of control objects includes a graphical icon having a selection portion and a properties portion and one or more control properties that affect one or more items within the main application window.

Abstract: The invention relates to the combination of nitrogenated heterocyclic antibacterial compounds of formula (I) with other antibacterial compounds and the use of same as drugs. The nitrogenated heterocyclic compounds are of general formula (I) wherein R1 represents a (CH2)n-NH2 or (CH2)n—NHR radical, where R is a (C1-C6) alkyl and n is equal to 1 or 2; R2 represents a hydrogen atom; R3 and R4 together form an aromatic nitrogenated heterocycle with 5 apexes with 1, 2 or 3 nitrogen atoms optionally substituted by one or several R? groups, R? being selected in the group composed of a hydrogen atom and the alkyl radicals with 1 to 6 carbon atoms, in free form, as zwitterions, and in the form of salts of pharmaceutically acceptable inorganic or organic bases and acids.

Abstract: A composition for removing urethane products from a wide variety of substrates without the need for scraping, scrubbing, sanding, sandblasting and the like is provided. The composition is formed by combining water, a polar organic solvent, a mixture of organic esters, a hydrocarbon, and a polyether. The composition may optionally be formed by combining the components recited above along with an anionic surfactant. The composition may optionally be formed by combining the components recited above along with a thickener.

Abstract: A composition for removing urethane products from a wide variety of substrates without the need for scraping, scrubbing, sanding, sandblasting and the like is provided. The composition is formed by combining water, a polar organic solvent, a mixture of organic esters, a hydrocarbon, and a polyether. The composition may optionally be formed by combining the components recited above along with an anionic surfactant. The composition may optionally be formed by combining the components recited above along with a thickener.

Abstract: A computing system for providing a user interface control to modify properties of items within a main application window. The computing system has a main application window, a gallery control window, a control object selection processing module, and a control object focus processing module. The main application window contains one or more application items, each application item having one or more control properties affecting a behavior of the application item. The gallery control window contains a list of one or more control objects for modifying control properties of the application items located within the main application window. Each of the control objects in the list of control objects includes a graphical icon having a selection portion and a properties portion and one or more control properties that affect one or more items within the main application window.

Abstract: A computing system for providing a user interface control to modify properties of items within a main application window. The computing system has a main application window, a gallery control window, a control object selection processing module, and a control object focus processing module. The main application window contains one or more application items, each application item having one or more control properties affecting a behavior of the application item. The gallery control window contains a list of one or more control objects for modifying control properties of the application items located within the main application window. Each of the control objects in the list of control objects includes a graphical icon having a selection portion and a properties portion and one or more control properties that affect one or more items within the main application window.

Abstract: A shoreline riding toy, for use in hydroplaning along a thin layer of water at a shoreline, having a rigid lower board having a hard and slick bottom surface, and a soft, inflatable upper portion. The upper portion is adhered to the lower board. The upper portion overhangs the lower board in all horizontal directions. The upper portion supports the user such that when the user runs and dives while holding the toy to initiate hydroplaning of the lower board on the thin layer of water, the upper portion suspends the user above the lower board for the comfort and safety of the user.

Abstract: A portable wipe product for use in cleaning objects, such as pacifiers, bottles, teething objects, and cups that are to be placed in a child's mouth. The wipes are dispensed from a portable dispenser. The wipes are covered with an aqueous mixture that, in its basic form, includes purified water, one of an emulsifier and a surfactant, a moisture preserving agent, a chelator, a preservative, and an acidulant. Flavoring and an anti-oxidant may also be added.

Abstract: The present invention provides a method for screening for antimicrobial compounds using in a whole cell assay using bacteria, particularly bacteria of the genus Staphylococcus and Streptococcus.

Abstract: A pharmaceutical formulation comprises, in combination with a penem of formula (I): in which: R1 is hydrogen or an organic substituent group; R2 is a fused bicyclic heterocyclic ring system of general formula:  wherein R4 and R5 are independently hydrogen or one or more substituents replacing hydrogen atoms in the ring system shown; m is 2 or 3; p is zero, 1 or 2; and R3 is hydrogen, a salt-forming cation or an ester-forming group; and the symbol ═/═ indicates that the double bond may be in either the E or Z configuration; and a pharmaceutically acceptable carrier; a &bgr;-lactam antibiotic selected from the group consisting of ceftazidime, cefotaxime, amoxycillin, and piperacillin, and pharmaceutically acceptable derivatives thereof.

Abstract: A portable wipe product for use in cleaning objects, such as pacifiers, bottles, teething objects, and cups that are to be placed in a child's mouth. The wipes are dispensed from a portable dispenser. The wipes are covered with an aqueous mixture that, in its basic form, includes purified water, one of an emulsifier and a surfactant, a moisture preserving agent, a chelator, a preservative, and an acidulant. Flavoring and an anti-oxidant may also be added.

Abstract: Pharmaceutical formulations comprising ceftriaxone in combination with a penem of formula (I) in which R.sup.1 is hydrogen or an organic group; R.sup.2 is a ring system of formula (II), wherein R.sup.4 and R.sup.5 are hydrogen or one or more substituents; m is 2 or 3; p is 0, 1 or 2; R.sup.3 is hydrogen, a pharmaceutically acceptable salt-forming cation or a pharmaceutically acceptable in-vivo hydrolysable ester-forming group; and with a pharmaceutically acceptable carrier. The formulations have antibacterial activity, the compound of formula (I) acting as a .beta.-lactamase inhibitor.

Abstract: A pharmaceutical formulation comprises, in combination with a penem of formula (I): ##STR1## in which: R.sup.1 is hydrogen or an organic substituent group;R.sup.2 is a fused bicyclic heterocyclic ring system of general formula: ##STR2## wherein R.sup.4 and R.sup.5 are independently hydrogen or one or more substituents replacing hydrogen atoms in the ring system shown; m is 2 or 3; p is zero, 1 or 2; and R.sup.3 is hydrogen, a salt-forming cation or an ester-forming group; and the symbol =/= indicates that the double bond may be in either the E or Z configuration; and a pharmaceutically acceptable carrier; a .beta.-lactam antibiotic selected from the group consisting of ceftazidime, cefotaxime, amoxycillin, and piperacillin, and pharmaceutically acceptable derivatives thereof.

Abstract: A pharmaceutical formulation comprises, in combination with a penem of formula (I), in which: R.sup.1 is hydrogen or an organic substituent group; R.sup.2 is a fused bicyclic heterocyclic ring system of general formula (a), wherein R.sup.4 and R.sup.5 are independently hydrogen or one or more substituents replacing hydrogen atoms in the ring system shown; m is 2 or 3; p is zero, 1 or 2; and R.sup.3 is hydrogen, a salt-forming cation or an ester-forming group; and the symbol .dbd./.dbd. indicates that the double bond may be in either the E or Z configuration; and a pharmaceutically acceptable carrier, a .beta.-lactam antibiotic selected from the group consisting of ceftazidime, cefotaxime, amoxycillin, and piperacillin, and pharmaceutically acceptable derivatives thereof.

Abstract: A pharmaceutical formulation comprises, in combination with a penem of formula (I): ##STR1## in which: R.sup.1 is hydrogen or an organic substituent group;R.sup.2 is a fused bicyclic heterocyclic ring system of general formula: ##STR2## wherein R.sup.4 and R.sup.5 are independently hydrogen or one or more substituents replacing hydrogen atoms in the ring system shown; m is 2 or 3; p is zero, 1 or 2; and R.sup.3 is hydrogen, a salt-forming cation or an ester-forming group; and the symbol .dbd./.dbd. indicates that the double bond may be in either the E or Z configuration; and a pharmaceutically acceptable carrier; a .beta.-lactam antibiotic selected from the group consisting of ceftazidime, cefotaxime, amoxycillin, and piperacillin, and pharmaceutically acceptable derivatives thereof.